News and Comments

Like Dendreon (DNDN) Human Genome might have Bottomed

  Monday, January 09, 2012

As expected, Human Genome Sciences (HGSI) will report on progress with the commercialization of Benlysta® (belimumab) during a presentation at the 30th Annual JPMorgan Healthcare Conference in San Francisco. The drug is approved for the treatment of adult patients with active autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy. More...

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...

Recent Postings



Rapamune Mirati Therapeutics (MRTX) ABBVIE (ABBV) galapagos (GLPG) NANTKWEST (NK) Dendreon (DNDN) Micromet (MITI) SUNESIS PHARMACEUTICALS (SNSS) Sanofi-Aventis (SAN) Intercept (ICPT) AERIE PHARMACEUTICALS Sequenom (SQNM) ZALTRAP™ AGOS (ARGS) Alder Biopharmaceuticals (ALDR) Galena (GALE) OSI (OSIP) BIOMARIN (BMRN) Revlimid (lenolidamide) Sanofi (SNY) Intermune (ITMN) Agenus (AGEN RenenxBio (RGNX) Theravance (THRX) HALOZYME (HALO) Prolor Biotech (PBTH) Ionis (IONS) C4 Therapeutics Telaprevir KITE (KITE) Pluristem (PSTI) Editas (EDIT) Spike Therapeutics (ONCE) Endometrial Cancer NEKTAR (NKTR)) SYNTA (SNTA) ACADIA (ACAD) Roche (RHHBY) IDERA (IDRA) Theravance Bio Pharma (TBPH) ARCA (ABIO) Ziofpharm (ZIOP) CompuGen (CGEN) Human Longevity (HLI) ImmunoGen (IMGN) Abbott Laboratories (ABT) Bristol-Myers Squibb (BMY) Xoma (XOMA) ARGOS (ARGS) Velcade (bortezomib) Human Genome Sciences (HGSI) Benlysta (belimumab) Roche (ROCHE) Elan (ELN) VANDA (VNDA) Dynavax (DVAX) TOKAI (TKAOI) Ridaforolimus GUARDIAN HEALTH Gilead (GILD) Incyte (INCY) Vertex (VRTX) Cytokinetics (CYTK) Agenus (AGEN) Array Pharmaceuticals (ARRY) GlaxoSmithKline (GSK) Onyx (ONXX) Anadys (ANDS) Inovio (INO) Biogen Idec (BIIB) Idenix (IDIX) Sangamo (SGMO) Anacor (ANAC) REGULUS (RGLS) Aimmune Therapeutics (AIMT) Herceptin Illumina (ILMN) Tysabri KERYX (KERX) Sarepta (SRPT) Prosensa (RNA) JUNO (JUNO) Biocryst (BCRX) ADVENTRIX (ANX) Global Cell Therapeutics (GBT) ISIS (ISIS) Vitae Pharmaceuticals (VTAE) Intrexon (XON) Auspex (ASPX) Ariad (ARIA) Valeant Pharmaceuticals International (VRX) Seattle Genetics (SGEN) Exelixis (EXEL) Alnylam (ALNY) Merck (MRK) PTC Therapeutics (PTCT) Amgen (AMGN) Zerenex Jazz Pharmaceuticals (JAZZ) INNOVIVA (INVA) Regeneron (REGN) Trastuzumab-DM1 SERES THERAPEUTICS (MCRB) Genentech Multiple Myeloma Sanofi (SNA)